MITA's new set of management standards for CT equipment aims to help manufacturers comply with dose mitigation and reporting features.
A new set of management standards for CT equipment aims to help manufacturers comply with dose mitigation and reporting features.
The Medical Imaging and Technology Alliance (MITA)’s Smart Dose - formally known as XR-29 Standard Attributes on Computer Tomography (CT) Equipment Related to Dose Optimization and Management - was announced last month and combines four features of CT equipment that help optimize the management of radiation dose: DICOM Dose Structured Reporting, pediatric and adult reference protocols, CT Dose Check, and Automatic Exposure Controls.
“There are no new features in XR-29, but rather the idea was to pull dose mitigation and dose reporting features into one standard that manufacturers can note on their equipment as being compliant with,” Gail Rodriguez, executive director of MITA, said in an interview. “This was done with the hope that if you put those separate features into a standard it can help to drive adoption and utilization among healthcare and imaging providers.”
MITA’s announcement was backed by comments from both the Deputy Director for Radiological Health at the FDA and other industry leaders
“Above all, the medical imaging team that includes the manufacturers of imaging equipment are committed to putting the patient’s safety, health and welfare first,” Marilyn Goske, MD, of Cincinnati Children’s and Chair of the Image Gently campaign, said in a release. “The approval of this new CT standard represents another important step forward in ensuring patients, particularly children, have access to the safest, most advanced technology available.”
Equipment that meets the new Smart Dose standards will include:
“This is a result of all of the imaging community working together,” Rodriguez said. “There is a galvanized effort to include new features on imaging scanners to reduce dose without sacrificing image quality.”
Since the new standards were announced, both Toshiba and Siemens have announced measures to comply with the new standards. Toshiba announced that all of its new Aquilion CT systems will meet the standards, and Siemens Healthcare announced that all of its new Somatom CT products will as well.
“It is our collective hope,” Rodriquez said, “that this will drive compliance, and help providers to say that they are doing everything that they can to make sure that patient safety is guarded.”
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.